Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA

BACKGROUND: Adverse Drug Reactions (ADRs) are of great public health concern. FDA-approved drug labeling summarizes ADRs of a drug product mainly in three sections, i.e., Boxed Warning (BW), Warnings and Precautions (WP), and Adverse Reactions (AR), where the severity of ADRs are intended to decreas...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Bioinformatics
Main Authors: Wu, Leihong, Ingle, Taylor, Liu, Zhichao, Zhao-Wong, Anna, Harris, Stephen, Thakkar, Shraddha, Zhou, Guangxu, Yang, Junshuang, Xu, Joshua, Mehta, Darshan, Ge, Weigong, Tong, Weida, Fang, Hong
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2019
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6419320/
https://ncbi.nlm.nih.gov/pubmed/30871458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12859-019-2628-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares